uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Common Equity (2015 - 2026)

uniQure (QURE) posted quarterly Common Equity of $324.0 million for Q2 2026, up 8195.18% year-over-year from $3.9 million in Q2 2025, and up 116.98% quarter-over-quarter from $149.3 million in Q1 2026.

Analysis

uniQure (QURE) Common Equity (2015 - 2026) Analysis & Trends

uniQure's Common Equity history runs 12 years deep, the most recent figure standing at $324.0 million for Q2 2026.

  • In Q2 2026, Common Equity rose 8195.18% year-over-year to $324.0 million; the TTM figure through Jun 2026 stood at $324.0 million (up 8195.18% YoY), while the FY2025 annual figure was $198.9 million, up 3045.81% from the prior year.
  • Common Equity for Q2 2026 stood at $324.0 million, up from $149.3 million in the prior quarter.
  • The five-year high for Common Equity was $546.0 million in Q1 2022, with the low at -$6.8 million in Q4 2024.
  • The 5-year median for Common Equity is $218.2 million (2023), against an average of $244.2 million.
  • The sharpest annual moves came in 2025 and 2026: Common Equity slumped 104.12% in 2025, then soared 8195.18% in 2026.
  • uniQure's Common Equity stood at $476.0 million in 2022, then slumped by 56.37% to $207.7 million in 2023, then plunged by 103.25% to -$6.8 million in 2024, then surged by 3045.81% to $198.9 million in 2025, then surged by 62.92% to $324.0 million in 2026.
  • Business Quant data shows QURE's Common Equity at $324.0 million in Q2 2026, $149.3 million in Q1 2026, and $198.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 20.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 31.71 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.42 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 6.76 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.61 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.17 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.35 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 9.79 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 757.49 Mn
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 324.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 324.05 Mn
Mar 31, 2026 149.34 Mn
Dec 31, 2025 198.90 Mn
Sep 30, 2025 228.75 Mn
Jun 30, 2025 -4.00 Mn
Mar 31, 2025 33.69 Mn
Dec 31, 2024 -6.75 Mn
Sep 30, 2024 55.82 Mn
Jun 30, 2024 97.11 Mn
Mar 31, 2024 146.75 Mn
Dec 31, 2023 207.67 Mn
Sep 30, 2023 268.78 Mn
Jun 30, 2023 353.32 Mn
Mar 31, 2023 412.77 Mn
Dec 31, 2022 476.01 Mn
Sep 30, 2022 421.17 Mn
Jun 30, 2022 486.49 Mn
Mar 31, 2022 546.00 Mn
Dec 31, 2021 595.78 Mn
Sep 30, 2021 590.76 Mn